JP2001503755A5 - - Google Patents

Download PDF

Info

Publication number
JP2001503755A5
JP2001503755A5 JP1998521140A JP52114098A JP2001503755A5 JP 2001503755 A5 JP2001503755 A5 JP 2001503755A5 JP 1998521140 A JP1998521140 A JP 1998521140A JP 52114098 A JP52114098 A JP 52114098A JP 2001503755 A5 JP2001503755 A5 JP 2001503755A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998521140A
Other languages
English (en)
Other versions
JP2001503755A (ja
Filing date
Publication date
Priority claimed from GBGB9622852.3A external-priority patent/GB9622852D0/en
Priority claimed from GBGB9709494.0A external-priority patent/GB9709494D0/en
Priority claimed from GBGB9717791.9A external-priority patent/GB9717791D0/en
Application filed filed Critical
Priority claimed from PCT/GB1997/003015 external-priority patent/WO1998020027A2/en
Publication of JP2001503755A publication Critical patent/JP2001503755A/ja
Publication of JP2001503755A5 publication Critical patent/JP2001503755A5/ja
Withdrawn legal-status Critical Current

Links

Description

Figure 2001503755
Figure 2001503755
Figure 2001503755
Figure 2001503755
JP52114098A 1996-11-01 1997-11-03 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用およびデリバリー装置 Withdrawn JP2001503755A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9622852.3A GB9622852D0 (en) 1996-11-01 1996-11-01 Treatment of intimal hyperplasma
GB9622852.3 1996-11-01
GBGB9709494.0A GB9709494D0 (en) 1997-05-09 1997-05-09 Delivery device and method
GB9709494.0 1997-05-09
GB9717791.9 1997-08-21
GBGB9717791.9A GB9717791D0 (en) 1997-08-21 1997-08-21 Treatment of intimal hyperplasia
PCT/GB1997/003015 WO1998020027A2 (en) 1996-11-01 1997-11-03 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2008004349A Division JP4783797B2 (ja) 1996-11-01 2008-01-11 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置
JP2011236266A Division JP2012031196A (ja) 1996-11-01 2011-10-27 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置

Publications (2)

Publication Number Publication Date
JP2001503755A JP2001503755A (ja) 2001-03-21
JP2001503755A5 true JP2001503755A5 (ja) 2005-06-16

Family

ID=27268562

Family Applications (3)

Application Number Title Priority Date Filing Date
JP52114098A Withdrawn JP2001503755A (ja) 1996-11-01 1997-11-03 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用およびデリバリー装置
JP2008004349A Expired - Fee Related JP4783797B2 (ja) 1996-11-01 2008-01-11 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置
JP2011236266A Pending JP2012031196A (ja) 1996-11-01 2011-10-27 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008004349A Expired - Fee Related JP4783797B2 (ja) 1996-11-01 2008-01-11 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置
JP2011236266A Pending JP2012031196A (ja) 1996-11-01 2011-10-27 Ｎｏまたはプロスタサイクリン産生を刺激する薬剤の治療的使用および送達装置

Country Status (15)

Country Link
US (1) US7320679B2 (ja)
EP (2) EP0941116B1 (ja)
JP (3) JP2001503755A (ja)
KR (1) KR100695590B1 (ja)
AT (1) ATE287271T1 (ja)
AU (1) AU729420B2 (ja)
CA (1) CA2270286C (ja)
DE (1) DE69732304T2 (ja)
ES (1) ES2235227T3 (ja)
HK (1) HK1108845A1 (ja)
HU (1) HU223957B1 (ja)
NO (1) NO326303B1 (ja)
PL (1) PL189744B1 (ja)
PT (1) PT941116E (ja)
WO (1) WO1998020027A2 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
US20080305999A1 (en) * 1996-11-01 2008-12-11 John Francis Martin Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
CA2304354A1 (en) * 1997-10-02 1999-04-15 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
GB9809082D0 (en) 1998-04-28 1998-06-24 Eurogene Limited Delivery device
DK1112083T3 (da) * 1998-09-09 2004-03-08 Univ Washington Behandling af mikrovaskulære angiopatier
US6596699B2 (en) 1998-09-22 2003-07-22 Biosurface Engineering Technologies, Inc. Nucleic acid coating compositions and methods
US6958147B1 (en) 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
CZ20013813A3 (cs) * 1999-04-26 2002-02-13 Aventis Pharma S. A. Pouľití defektního rekombinantního adenovirového vektoru obsahujícího nukleovou kyselinu kódující angiogenní faktor pro výrobu léku k léčení plicní hypertenze
FR2792531B1 (fr) * 1999-04-26 2003-01-31 Aventis Pharma Sa Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire
AU5724499A (en) * 1999-09-23 2001-04-24 An-Go-Gen Inc. Cell-based gene therapy for the pulmonary system
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
CA2385665A1 (en) * 1999-11-02 2001-05-10 Genentech, Inc. Modulation of enos activity and therapeutic uses thereof
SE0000285D0 (sv) * 1999-12-07 2000-01-31 Mika Lahtinen Medical implant
EP1259626B1 (en) 2000-02-25 2007-10-31 Ludwig Institute For Cancer Research Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
GB0012997D0 (en) * 2000-05-26 2000-07-19 Eurogene Limited Gene delivery
WO2002096469A2 (en) * 2001-05-29 2002-12-05 Ark Therapeutics Ltd. Gene delivery via a baculovirus vector
JP2004533890A (ja) * 2001-07-06 2004-11-11 トリカーディア，エル．エル．シー． 抗不整脈デバイスおよびその使用方法
SE0102578L (sv) * 2001-07-20 2003-01-21 Oeyvind Reitan Förändring av en stents egenskaper för att förhindra restenos
US20060154884A1 (en) * 2003-06-18 2006-07-13 Arnd Buchwald Use of a vegf receptor gener or gene product
GB0515140D0 (en) 2005-07-22 2005-08-31 Ark Therapeutics Ltd Therapeutic device
ES2363758T3 (es) 2005-08-15 2011-08-16 Vegenics Pty Ltd Vegf y pdgf modificados con propiedades angiogénicas mejoradas.
CN101405408A (zh) * 2006-01-18 2009-04-08 通用医疗公司 增强淋巴功能的方法
US8721711B2 (en) 2007-06-20 2014-05-13 Oregon Health & Science University Graft having microporous membrane for uniform fluid infusion
CA2746807A1 (en) 2007-12-14 2009-06-25 Oregon Health & Science University Drug delivery cuff
DE102008002396A1 (de) 2008-06-12 2009-12-17 Biotronik Vi Patent Ag Implantierbares Wirkstoffreservoir und Vorrichtung mit einem implantierbaren Wirkstoffreservoir
EP3311830A1 (en) * 2012-02-14 2018-04-25 The Regents of The University of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
KR102041381B1 (ko) 2012-03-12 2019-11-27 젬백스 에이에스 능동적인 면역치료법을 이용한 비-소세포성 폐암의 치료
AU2013296611B2 (en) 2012-08-01 2017-11-23 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with mesenchymal stem cells
US10080730B2 (en) 2013-01-09 2018-09-25 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
CN110177559A (zh) 2016-10-24 2019-08-27 联合治疗学有限公司 曲前列环素增强msc免疫调节性能
US20220235106A1 (en) * 2019-04-05 2022-07-28 Korea Institute Of Ceramic Engineering And Technology Method for expressing and purifying protein by using csq-tag
IT201900012537A1 (it) 2019-07-22 2021-01-22 Milano Politecnico Dispositivo di condizionamento per condizionare un tratto esposto di un vaso sanguigno e metodo

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
JPS56122317A (en) * 1980-02-29 1981-09-25 Koken:Kk Drug transporting material and its preparation
US5201728A (en) * 1991-05-03 1993-04-13 Giampapa Vincent C Subcutaneous implantable multiple-agent delivery system
US5326568A (en) * 1991-05-03 1994-07-05 Giampapa Vincent C Method of tissue-specific delivery
US5399352A (en) * 1993-04-14 1995-03-21 Emory University Device for local drug delivery and methods for using the same
WO1994028721A1 (en) * 1993-06-11 1994-12-22 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
US5653744A (en) * 1995-04-27 1997-08-05 Khouri Biomedical Research, Inc. Device and method for vascular anastomosis
US5830879A (en) * 1995-10-02 1998-11-03 St. Elizabeth's Medical Center Of Boston, Inc. Treatment of vascular injury using vascular endothelial growth factor

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000506994A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000509213A5 (ja)
JP2000500076A5 (ja)
JP2000507909A5 (ja)
JP2000500055A5 (ja)
JP2001518066A5 (ja)
JP2000500026A5 (ja)
JP2000502472A5 (ja)
JP2000501825A5 (ja)
JP2000512231A5 (ja)
JP2000502485A5 (ja)
JP2000502425A5 (ja)
JP2000501774A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000501876A5 (ja)
JP2002514255A5 (ja)
JP2002511979A5 (ja)
JP2000501744A5 (ja)
JP2001503755A5 (ja)
JP2000502316A5 (ja)
JP2001503287A5 (ja)